Background Diarrhea remains one of the major causes of
A cute diarrheal disease remains one of the major causes of morbidity and mortality in children under 5 years of age in Treatment of diarrhea consists of replacing lost fluids by means of oral rehydration impact, treatment aims at shortening the period of diarrhea. 3 Many studies have been conducted to evaluate adjuvant therapy to fluid and electrolyte management in cases of acute diarrhea. One such possible therapy is probiotics. 4 Probiotics are oral supplements or food products containing a sufficient number of viable microorganisms to alter the microflora of the host. They are now well-known for their beneficial effect in shortening diarrheal duration. The effect of probiotics involves different mechanisms, including direct antagonism to pathogens through competitive inhibition of adhesion to the epithelium and of intestinal mucin, bacteriocins or other antimicrobial molecules, promoting a "hostile" microenvironment for pathogens, and immune stimulation. 5 Heat-killed do not produce active metabolites, though they still have effect on human immunity. However, there have been varied results on the effect of probiotics highlighted the beneficial effect of probiotics as an add-on treatment to ORS in shortening the duration 6 Lactobacillus acidophillus duration. 7 These results were consistent with a study 8 Different results were reported by Warouw et al. in a trial of children with acute diarrhea. Tyndallized probiotics Lactobacillus sporogenes and Lactobacillus acidophilus showed no differences in reducing the duration of acute diarrhea (3.32 days versus 2.52
The objective of our study was to assess the effectiveness of live compared to heat-killed probiotics for reducing frequency and duration of diarrhea, as well as improving weight gain in children with acute diarrhea.
Methods
We conducted a randomized, single-blind, controlled pediatric wards of Soeradji Tirtonegoro Klaten Hospital, Banyumas and Rembang District Hospitals. Subjects were collected by consecutive sampling. The required sample size was calculated to be months with acute diarrhea, without dehydration or with mild dehydration, who had less than a 7 dayduration of diarrhea, and whose parents consented.
antibiotics or antidiarrheal medications in the three weeks prior to or during the study, those with bloody diarrhea, malnutrition before entering the hospital, and those who had complications such as severe dehydration, metabolic acidosis, seizures, renal failure, and sepsis. All subjects' parents gave written informed consent.
Medical history was recorded at the time of admission by two pediatric residents and physical nutritional status, as well as the degree of dehydraon WHO criteria, rehydration was given according to WHO guidelines, with the administration of oral feeding. After patients were clinically stabilized, they received live probiotics (Lacto-B ® probiotics (Dialac ® they received, while researchers and nurses were aware of the study. All subjects were managed based on standard therapy. Probiotic preparations were prescribed twice per day for five days and administered orally in so that live and heat-killed probiotics could not be hours, while evaluation and measurement of body weight were done at the end of the study. Frequency of diarrhea (defined as the number of times the patients of therapy were recorded by parents or nurses in the study form. All patients were observed for stool passage everyday, including stool consistency, frequency and duration of diarrhea (the time in hours from the first to the last abnormal, loose or liquid stools precedbetween the time the patient consumed probiotic preparations until the stool became solid. Recovery from diarrhea was defined as when the frequency of defecation dropped to less than three times per day. We also investigated safety and tolerability of the probiotics.
The independent variables were live and heatkilled probiotics, while the dependent variable was the effectiveness of therapy, as measured by the duration and frequency of diarrhea and weight change.
of dehydration and duration of diarrhea before time of admission.
The primary outcome measured in this intervention was duration of diarrhea, while the secondary outcome included frequency of diarrhea and body Data was analyzed with SPSS for Windows the independent t-test and dichotomous variables confidence interval. This study was approved by the Results who were hospitalized with acute diarrhea. They were randomly divided into 2 groups. Live probiotics were given to 83 subjects and heat-killed probiotics were given to 82 subjects. No subjects were lost to follow-up. The study program sequence is shown in Figure 1 .
The demographic and clinical characteristics of subjects in both groups are shown in Table 1 .
The decrease in diarrheal frequency to < three Table 2 . There were no statistically significant differences in frequency at any day between the two groups.
The duration and frequency of diarrhea, as well as weight change of the subjects are shown in Table 3 . 
Discussion
Our results show no significant differences between live and heat-killed probiotics in reducing the duration and frequency of diarrhea or in weight gain.
produced during fermentation (bacteriocin, product, resulting in heat-killed probiotic potency similar to that of live probiotics. Heat-killed probiotics also contain antigens that can stimulate the mucosal immune system when consumed. Heatkilled probiotics are unable to proliferate in the gastrointestinal tract, and they, therefore, do not cause translocation of antibiotic resistance genes, are not affected by stomach acidity, are more stable, the intestinal epithelial cells and at least temporarily colonize the intestine. Although the beneficial effects of probiotic agents for normal hosts, including children with diarrheal illnesses, are well-documented, probiotic therapy may be associated with occasional adverse effects, such as bacteremia, sepsis, or endocarditis, for a select subset of patients, such as immunocompromised or severely debilitated hosts. Rare cases of local or systemic infections including septicemia and endocarditis due to lactobacilli, bifidobacteria or other lactic bacteria have been reported with nearly all patients having had serious underlying fatal diseases which predisposed them to infection. Abnormal heart valves in the case of endocarditis, and the presence of a catheter in cases of septicemia are known risk factors, but other or pregnancy have not been identified as risk factors for LAB or other probiotic infections. adverse events were not found in either group and the probiotics were well-tolerated. Lands et al. reported two cases of sepsis associated with probiotics in adults, but reports of serious infections associated with probiotic lactobacilli are rare. The pathogenesis of infection attributable to Lactobacillus species is poorly understood. Adhesion of probiotic strains to the intestinal mucosa and subsequent colonization are considered important prerequisites for probiotic action, because they prolong persistence in the intestine.
et al. concluded that Lactobacillus is safe and effective as a therapy for the use of probiotics is safe, but we should carefully consider the use of probiotics in patients at high risk of systemic infections, such as immunocompromised or critically ill patients. his study, heat-killed probiotics were better at reducing results should be interpreted with caution due to the limitations of the study, as probiotic preparation was not standardized, and it is known that live probiotics will die at high temperatures. Furthermore, the cause of diarrhea was unknown. 8 Simakachom et al.
oral rehydration in children with diarrhea. They found that the addition of L. acidophilus to the oral rehydration reduced the length of diarrhea. This result may be due to heat-killed bacteria having an inherent ability in the human gut to inhibit pathogenic bacterial processes. 7 Weizman et al. reported that baby food supplemented with L. reuteri or B. lactis had fewer episodes and shorter duration of diarrhea. Lactobacilli may influence the incidence of infections by stimulating nonspecific immunity or enhancing humoral and cellular immune mechanisms. This immunostimulatory effect of bacteria has been shown to prevent recurrent infections in children. Lactic to manage intestinal disorders such as lactose intolerance, acute gastroenteritis due to rotavirus and other enteric pathogens, adverse effects of pelvic radiotherapy, constipation, inflammatory bowel may occur during disease states associated with disturbances of the intestinal microflora and various degrees of inflammation of the intestinal mucosa. To successfully treat these conditions, a probiotic strain should be able to survive gastric acidity, adhere to
